found that IL-35 inhibited angiogenesis and inflammation of rheumatoid arthritis by down-regulating basal and VEGF-induced angiopoietin-2 secretion and interfering with Ang2/Tyrosine kinase receptors signal transduction in human umbilical vein endothelial cells (32). This evidence concerns the gene NTRK1 and rheumatoid arthritis.